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The structure and function of the barrier layers restricting the free diffusion of substances
between the central nervous system (brain and spinal cord) and the systemic circulation is
of great medical interest as various pathological conditions often lead to their impairment.
Excessive leakage of blood-borne molecules into the parenchyma and the concomitant
fluctuations in the microenvironment following a transient breakdown of the blood-brain
barrier (BBB) during ischemic/hypoxic conditions or because of an autoimmune disease
are detrimental to the physiological functioning of nervous tissue. On the other hand,
the treatment of neurological disorders is often hampered as only minimal amounts of
therapeutic agents are able to penetrate a fully functional BBB or blood cerebrospinal
fluid barrier. An in-depth understanding of the molecular machinery governing the
establishment and maintenance of these barriers is necessary to develop rational
strategies allowing a controlled delivery of appropriate drugs to the CNS. At the basis of
such tissue barriers are intimate cell-cell contacts (zonulae occludentes, tight junctions)
which are present in all polarized epithelia and endothelia. By creating a paracellular
diffusion constraint TJs enable the vectorial transport across cell monolayers. More recent
findings indicate that functional barriers are already established during development,
protecting the fetal brain. As an understanding of the biogenesis of TJs might reveal
the underlying mechanisms of barrier formation during ontogenic development numerous
in vitro systems have been developed to study the assembly and disassembly of TJs.
In addition, monitoring the stage-specific expression of TJ-associated proteins during
development has brought much insight into the “developmental tightening” of tissue
barriers. Over the last two decades a detailed molecular map of transmembrane and
cytoplasmic TJ-proteins has been identified. These proteins not only form a cell-cell
adhesion structure, but integrate various signaling pathways, thereby directly or indirectly
impacting upon processes such as cell-cell adhesion, cytoskeletal rearrangement, and
transcriptional control. This review will provide a brief overview on the establishment of
the BBB during embryonic development in mammals and a detailed description of the
ultrastructure, biogenesis, and molecular composition of epithelial and endothelial TJs will
be given.
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Abbreviations: CD31/34, cluster of differentiation 31/34; Cdc42, cell division con-
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During evolution organisms with a complex nervous system
have developed mechanisms to selectively restrict the blood-
to-brain traffic of compounds allowing a tight regulation
of the neuroparenchymal microenvironment. Such cerebral
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www.frontiersin.org December 2014 | Volume 8 | Article 392 | 1
Bauer et al. BBB—morphology, molecules, and function
homeostasis is fundamental for proper function of synapses and
neural networks. However, despite the burgeoning literature on
when the BBB is established in the course of mammalian devel-
opment, the topic is still heavily debated. This is largely the result
of inconsistent and partially contradictive results stemming from
different animal models used and due to misinterpretation of
experiments (for review see Saunders et al. in this volume). In
addition, not a single barrier, but the sum of several cellular
and molecular barriers ensures the stable environment needed
for the proper function of the central nervous system, further
complicating the analysis. Of the three main CNS barriers the
brain endothelium constituting the blood-brain barrier (BBB)
represents the major interface between the blood and the brain
interstitial fluid with an estimated total surface area of 20m2
(Begley and Brightman, 2003). The endothelial cells are fitted
with specialized structures, such as cell-cell adhesion complexes
obliterating the paracellular space (tight junctions) and an array
of transport and shuttle proteins controlling the flux of ions and
solutes. The term BBB has been coined nearly 100 years ago by
Stern et al. (Stern and Rothlin, 1918; Stern and Gauthier, 1921),
implying a structure completely preventing an exchange between
blood and nervous tissue. However, since then it has become
increasingly clear that the BBB is a complex and dynamic struc-
ture allowing a controlled passage of blood-borne substances. In
addition, the functional BBB, at least in the adult, is not only
composed of the endothelial cells (ECs) lining the microvascula-
ture but also requires the contact and/or input of other cell types,
including astrocytes, neurons, and pericytes separated only by a
basement membrane. All these contributing building blocks of
the BBB are commonly being referred to as “neurovascular unit,”
a term which has been introduced for the first time by members
of the Stroke Progress Review Group in 2002 at the NIH, USA.
During embryonic development however, the composition of the
NVU and the nature of the cerebral capillary endothelial cells
(cECs) most likely is very different from those seen in the adult.
At an even more fundamental level, at which developmental stage
can we speak of a structure exerting barrier functions and does
BBB formation in cEC coincide with the early vascularization of
the growing CNS?
In mice angiogenesis in the brain begins at day E9 of devel-
opment, when pial vessels encircle the telencephalon (Vasudevan
et al., 2008). By E10 pial vessels sprout and start forming a
primitive vascular plexus within the telencephalon. The newly
formed vessels have a premature appearance (see Figures 1A,B)
but allow already erythrocyte traffic (Bauer et al., 1993, 1995).
In parallel, periventricular vessels migrate into the dorsal telen-
cephalon resulting in a ventrolateral to dorsomedial angiogen-
esis gradient (Vasudevan et al., 2008). It is proposed that the
pial vessels develop into venous sinuses and the periventricu-
lar vessels into arteries. The assumption that the plexus of the
CNS likely arises from two different endothelial cell populations
is further supported by the demonstration of different expres-
sion patterns of homeobox transcription factors, namely Dlx1/2,
Nkx2.1 in periventricular ventral vessels and Pax6 in pial vessels.
Intriguingly, these transcription factors also regulate neuroep-
ithelial cell proliferation and neuronal migration (Sussel et al.,
1999; Nery et al., 2003). Therefore, it is tempting to speculate
that angiogenesis in due course influences and regulates neuronal
proliferation and differentiation.
Several proteins, morphogenetic molecules and their recep-
tors are involved in both, angiogenesis of the brain and in
the formation of the BBB: VEGF has been identified as one
of the first of these effectors. This morphogenetic molecule is
secreted by neuronal precursor cells and promotes via binding
to endothelial tyrosine kinase receptors (FLT-1/VEGFR-1; FLK-
1/VEGFR-2) vessel sprouting during the early phases of CNS
development (Breier et al., 1992; Raab et al., 2004). VEGF is
also secreted by brain endothelial cells and exerts its influence
on the cortical cytoarchitecture during later stages of embryonic
development allowing the establishment of a functional neu-
ronal architecture in the CNS (Li et al., 2013). Other effector
molecules include members of the Wnt family (Wnt7a/b, Wnt3a)
together with the action of ß-catenin, Tie-2 (an endothelial cell-
specific receptor tyrosine kinase) and its ligands angiopoietin-1
and angiopoietin-2 (Ang-1, Ang-2), as well as sonic hedgehog
and Norrin (Engelhardt and Liebner, 2014). The important role
of Ang-1 during BBB formation is additionally strengthened by
the identification of SSeCKS, a soluble protein which induces the
expression of Ang-1 in cEC of the BBB (Lee et al., 2003). Next
to these effectors which exert their action throughout the entire
CNS, others are restricted to specific areas. For example GPR124
(orphan G protein-coupled receptor 124) is specifically expressed
in endothelial cells regulating sprouting in the forebrain and in
spinal cord but not in other regions of the CNS (Kuhnert et al.,
2010). GPR124 also modulates TGF-ß signaling, thereby influ-
encing pericyte and astrocyte differentiation and further impacts
upon glucose transport by regulating the expression of Glut-1 in
cECs. Taken together, the factors described above are intimately
related to the induction of a functional BBB as they promote dif-
ferentiation of the cECs, ultimately resulting in the formation
of occluding cell adhesion structures and the expression of spe-
cific transporter receptors and shuttling molecules such as the
multidrug resistance molecule.
The early transplantation experiments by Stewart and Wiley
and Ikeda et al. demonstrated the induction of BBB features of
invading endothelial cells by ectopic transplantation of embry-
onic brain tissue, indicating that the acquisition of BBB function
is not merely an intrinsic property of cerebral endothelial cells
(Stewart and Wiley, 1981; Ikeda et al., 1996) but requires the
direct and indirect communication with neighboring neuronal
cells. In the early brain these are the neuroepithelial cells and
neuroblasts and later in embryonic development and postna-
tally, neurons, pericytes and glial cells (Bauer and Bauer, 2000).
However, the underlying molecular machinery and ramifications
of this interaction are not fully understood mainly due to its
complex nature and its constant modulation during embryonic
and postnatal development. Lindahl et al. showed that platelet
derived growth factor–B (PDGF-B) secreted frommigrating cECs
led to the recruitment of pericytes and their attachment to the
newly formed vessels (Lindahl et al., 1997). In the following years
in vivo and in vitro studies demonstrated that pericytes are imper-
ative for BBB formation (Deli et al., 2005; Armulik et al., 2010;
Daneman et al., 2010b). Recently, another effector was described
by Ben-Zvi et al. (2014) namedMfsd2a, a transmembrane protein
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FIGURE 1 | Establishment of the intraneural vascular plexus and a
functional BBB during mouse embryogenesis. (A) Semithin section of
embryonic mouse neocortex at E10 showing the intraneural and parts of the
surrounding perineural domain (B) neuroepithelial cells surround a primitive
capillary (white arrow) containing a red blood cell (asterisk). Murine E13 (C)
and E17 (D) embryos microperfused with 0.5% Trypan blue solution. After
fixation specimens were cut medially and photographed. Arrowhead indicates
and enlarged area depicts stained choroid plexus (Bauer et al., 1993, 1995).
exclusively expressed in cerebral endothelial cells. Mfsd2a sup-
presses transcytosis in endothelial cells and thus the transport of
plasma proteins. Interestingly, the protein is expressed in mice at
embryonic day 13.5 and its expression depends on the presence
of pericytes. In Mfsd2a-knockout mice the BBB is impaired from
embryonic day 15.5 to adulthood what led the authors to the con-
clusion that vascularization and the establishment of a functional
BBB are not coinciding. In earlier findings however it has been
shown that the BBB becomes functional even before E15 (Bauer
et al., 1993, 1995). Microperfusion of E12–E13 mouse embryos
with Trypan Blue revealed that the CNS remained void of stain-
ing except for the choroid plexus anlage, indicating that at least
certain plasma proteins have been excluded (see Figures 1C,D).
Further, the number of pinocytotic vesicles in endothelial cells of
intraneural capillaries decreased from E12 onwards, whereas the
number of vesicles in endothelial cells of the perineural domain
in the CNS increased (see Table 1).
In summary, the formation of a functional BBB, or more
precisely, of a neurovascular unit with specific barrier struc-
tures and transport functions is a complex, multifactorial process
requiring the concerted action and interaction of various cell
types including cECs, astrocytes, neuronal and glial cells, as
well as pericytes. Finally, although the developmental stage at
which a functional BBB is present is still under debate, there is
good evidence that a barrier toward large molecules exists very
early in embryonic brain development, which then fully matures
postnatally.
TIGHT JUNCTION MORPHOLOGY AND FUNCTION
Next to an extensive transport machinery, tight junctions sealing
the microvascular endothelium represent the core structure of the
BBB. The tight junction (TJ) is the most apical cell-cell junction
complex in polarized epithelia and endothelia and can be visual-
ized by ultrathin-section electron microscopy as focal points or
“kissing points” where membranes of adjacent cells come into
close apposition, completely obliterating the intercellular cleft
(Farquhar and Palade, 1963). The application of freeze-fracture
electron microscopy provided a more detailed description of TJs.
TJs of epithelial cells appear as a complex network of anastomos-
ing and continuous cylindrical strands on the protoplasmic leaflet
(P-face) of the plasma membrane, with complementary grooves
on the exoplasmic leaflet (E-face), completely encircling the api-
cal aspect of the cell (Chalcroft and Bullivant, 1970; Staehelin,
1973, 1974; Van Deurs and Koehler, 1979). In contrast, depending
www.frontiersin.org December 2014 | Volume 8 | Article 392 | 3
Bauer et al. BBB—morphology, molecules, and function
Table 1 | Frequency of endothelial fenestrations (f), junctional complexes (j.c.) and pinocytotic vesicles (p.v.) in intraneural and perineural
capillaries during murine embryonic development.
Day of embryonic development Intraneural capillaries Perineural capillaries
f j.c. p.v. f j.c. p.v.
E9 No capillaries present 0.9 3.2 2.0
E10 nd 1.7 2.9 0.13 2.9 1.9
E12 nd 2.58 2.33 nd 3.25 3.0
E14 nd 2.29 1.57 nd 2.43 3.29
E17 nd 2.25 1.63 nd 2.75 4.13
Values were determined as follows: number of f, j.c., or p.v. divided by the number of capillaries examined (7–17 capillaries; mean values are shown). n.d., not
detected (Bauer et al., 1993).
on the vascular bed investigated, TJ strands of endothelial cells
generally display a significantly lower level of P-face association.
Whereas endothelial cells of the peripheral vasculature show pre-
dominantly E-face associated strands (Simionescu et al., 1976;
Muhleisen et al., 1989), freeze fracture replicas of TJs located
at the BBB reveal a high degree of P-face association and are
among the most complex found in the entire vasculature (Nagy
et al., 1984; Liebner et al., 2000b). It seems that not only the
complexity of the strand network but also the association of the
TJ-strands with the P- or E-face reflects the functional qual-
ity (i.e., permeability and electrical resistance) of the barrier
(Lippoldt et al., 2000). The varying P-face/E-face ratios possi-
bly are a consequence of altered attachment of the TJ strands to
the epithelial or endothelial cytoskeleton, but much detail is still
missing.
Next to the establishment andmaintenance of a size and charge
selective paracellular barrier (Gumbiner, 1987, 1993; Cereijido
et al., 1993), TJs also serve to create an intramembrane diffu-
sion barrier (“fence”) restricting the intermixing of apical and
basolateral components within the exoplasmic leaflet of plasma
membranes (Van Meer et al., 1986). In addition, they guide a
selective distribution and clustering of membrane components to
distinct cell-surfaces (Fanning and Anderson, 1999) and assem-
ble large protein complexes around scaffolding proteins at their
cytoplasmic aspect. The modular nature of these adaptor pro-
teins allows the spatial and temporal assembly of multi-protein
complexes not only ensuring the structural integrity of the TJ,
but also integrating various regulatory pathways which are pivotal
for TJ physiology, i.e., establishment of apico-basal polarity, gene
expression, and cell proliferation (Gonzalez-Mariscal et al., 2008;
Guillemot et al., 2008; Balda and Matter, 2009; McCrea et al.,
2009). Finally, the junctional cytoplasmic plaque provides a direct
and indirect link to the cytoskeleton.
Generally, much of our understanding of TJ biology stems
from studying polarized epithelial cells. However, several aspects
of the core structure of endothelial and epithelial TJs are simi-
lar and many of the reported findings apply most likely for both
cell types. The identification of an ever increasing number of
TJ-associated proteins (Gonzalez-Mariscal and Nava, 2005; Wang
and Margolis, 2007; Ebnet, 2008; Gonzalez-Mariscal et al., 2008;
Giepmans and Van Ijzendoorn, 2009; Steed et al., 2010; Bauer
et al., 2011) has led to a wide acceptance of the “protein model”,
proposing that linear arrays of polymerized transmembrane
adhesion molecules form TJ-strands and adhere with strands
from apposing plasmamembranes (Staehelin, 1973; Tsukita et al.,
2001; Furuse, 2010). However, it remains to be unequivocally
proven that the high transcellular electrical resistance of epithelia
and endothelia can solely be attributed to the molecular interac-
tion of TJ-strands. The involvement of lipid components (“lipid
model”) cannot be fully ruled out and a “lipid-protein hybrid
model” might explain the complexity of TJ physiology (Kan,
1993; Yamagata et al., 2003; Lee et al., 2008; Chen-Quay et al.,
2009). But information on the functional and structural rela-
tionship of proteins and lipids in the junctional complex remain
scarce.
THE BIOGENESIS OF TIGHT JUNCTIONS
Functional TJs not only seal the paracellular space between
epithelial and endothelial cells, they are also imperative for the
establishment of a polarized, transporting epithelial and endothe-
lial phenotype. The cellular constituents of tissue barriers are
polarized, displaying apico-basal polarity through the selective
distribution of specific lipid- and protein complexes to distinct
sites at the cell surface. Generally, the cells are oriented with their
apical aspect of the plasma membrane toward the lumen (“free
surface”), whereas the lateral domains are in close contact with
neighboring cells and basally adhere to other solid tissues (or
parenchyme), only separated by a basementmembrane. Epithelial
and endothelial cells grown in suspension, or loss of matrix
anchorage results in programmed cell death (anoikis), whereas
grown on a surface, even single cells polarize. Therefore, the con-
tact to the extracellular matrix, mainly conferred by the family
of integrin transmembrane proteins, is crucial to ensure robust
cell polarization and morphogenesis in vivo (Lee and Streuli,
2014). As soon as an appropriate vectorial transport machinery is
in place, epithelia and endothelia are considered fully differenti-
ated, separating tissue and organ compartments and allowing the
establishment and maintenance of distinct internal and external
milieus.
However, in spite of considerable structural similarities the
functional properties of epithelial and endothelial barriers in var-
ious tissues and organs can significantly vary. This is largely due to
the expression of different transmembrane (i.e., claudins; see fur-
ther below) and accessory TJ proteins. However, also parameters
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other than mere structural features need to be taken into account
when comparing barriers of various origin and organs. For exam-
ple, environmental factors (i.e., soluble factors or contacting cells)
can influence the barrier properties in developing and mature
organs. A beautiful example is the intimate association of cere-
bral endothelial cells with neuroectoderm-derived accessory cells
(astroglia, neurons, and neural precursor cells), which is a unique
feature of the BBB and imperative for its physiological function-
ing. These cells not only contribute physically to the barrier but
also induce barrier properties in differentiating cerebral endothe-
lial cells (Bauer and Bauer, 2000; Abbott, 2002; Haseloff et al.,
2005; Abbott et al., 2006; Weidenfeller et al., 2007).
Most of our knowledge about tissue barrier formation stems
from studies on epithelial and endothelial cells in vitro (Gonzalez-
Mariscal et al., 1985; Stevenson et al., 1988; Bauer et al., 2011;
Watson et al., 2013; Czupalla et al., 2014; Wilhelm and Krizbai,
2014). In this respect, particularly the re-establishment of TJs
following calcium depletion and the concomitant breakdown
of cell-cell contacts has been investigated (Gonzalez-Mariscal
et al., 1990; Contreras et al., 1992; Stuart et al., 1994). Much
of our understanding of TJ formation in primary (and sec-
ondary) epithelia also comes from studying embryogenesis of
D. melanogaster (cellularization) and C. elegans (Knust and
Bossinger, 2002; St Johnston and Ahringer, 2010). Mammalian TJ
biogenesis has mainly been described in cultured preimplantation
mouse embryos, which serve as a valuable model to determine
the expression of junctional proteins during the earliest steps
of cell lineage differentiation. Cultured preimplantation mouse
embryos can easily be manipulated to precisely determine the role
of junction-related proteins at early developmental stages such as
compaction and cavitation (formation of the blastocoel) (Dard
et al., 2008; Eckert and Fleming, 2008). Early signs of junction
establishment appear during formation of tubular structures or
cavities, a process which is fundamental to organ development
in both vertebrates and invertebrates. From a range of investiga-
tions describing the epithelial and endothelial tubular biogenesis,
three major morphologic mechanisms are being proposed, com-
monly referred to as cell hollowing, cord hollowing, and cavitation.
In all of them, tubes or cavities arise from lumenless, unpolar-
ized cell aggregates or single unpolarized cells. While cell and cord
hollowing are common in vascular structures, cavitation is rather
attributed to epithelial tubulogenesis and is only scarcely observed
in endothelial vessel formation (Lubarsky and Krasnow, 2003).
Cavitation has extensively been described in the preimplantation
mouse embryo and coincides with the first occurrence of a dif-
ferentiated epithelium in the mammalian embryo (Eckert and
Fleming, 2008). The undifferentiatedmammalian blastomeres are
subjected to three rounds of cleavage, resulting in the formation
of the eight-cell embryo, also referred to as the “early morula”
stage. Subsequently, compaction of the embryo is initiated, repre-
senting the moment of establishment of an epithelial phenotype
and the generation of an apical-basal axis. This asymmetric cel-
lular organization is then coupled with a specific orientation of
the mitotic spindle during cell division, resulting in asymmetric
division of the blastomeres giving rise to two different cell popu-
lations. The inner, non-polarized blastomeres form the inner cell
mass (ICM) of the blastocyst, and the outer polarized blastomeres
giving rise to the first polarized epithelium, the trophectoderm
(TE) which develops into the chorioallantoic placenta later dur-
ing development. The ICM then develops into the epiblast, the
origin of all tissues of the embryo proper, and the primitive endo-
derm which gives rise to the extra-embryonic membranes. A
more detailed description on embryonic axis establishment and
blastocyst lineage formation is beyond the scope of this review
and the reader is referred to a series of excellent reviews (Larue
et al., 1994; Arnold and Robertson, 2009; Rossant and Tam,
2009; Morris and Zernicka-Goetz, 2012; Takaoka and Hamada,
2012).
Overall, premature intercellular contacts serve as an initial
spatial cue for the establishment of polarity not only in blas-
tomeres but also in cells in general. Early studies then identified
E-cadherin as the prime epithelial signature marker. During com-
paction of the early mouse embryo, diffusely localized E-cadherin
becomes redistributed to long filopodia protruding from the blas-
tomeres which facilitate the attachment of two neighboring cells
via homophilic binding of opposing E-cadherin clusters (Fierro-
Gonzalez et al., 2013). Interestingly, mouse embryos deficient in
E-cadherin fail to form a proper trophectoderm and die around
the time of implantation, compaction not being affected. This
late phenotype is explained by the presence of a residual mater-
nal E-cadherin pool, which is sufficient to drive compaction
(Larue et al., 1994). Next to E-cadherin, the homophilic bind-
ing of nectin family members at developing adhesive structures
takes place very early during the establishment of the polar-
ized epithelial phenotype (Sato et al., 2006; Takai et al., 2008b).
Nectins constitute a family of single-pass, calcium-independent
transmembrane adhesive molecules which, together with clus-
ters of cadherins form mature adherens junctions (Indra et al.,
2013). During the early phases of polarization it is believed that
nectin controls the initiation of cadherin clustering by prevent-
ing the endocytotic removal of cadherin (Takai et al., 2008a).
The majority of nectin function is conferred via its association
with the cytoplasmic protein afadin, which allows cross-talk with
other junctional complexes. Afadin not only functionally cou-
ples the E-cadherin and nectin complex (Tachibana et al., 2000),
but also directly interacts with the TJ-associated protein JAM-
A, thereby influencing tight junction assembly during further
progression of the polarity program (Fukuhara et al., 2002). JAM-
A assembles at the cell membranes of the early 8-cell mouse
embryo prior to compaction and unlike any other TJ constituent
its recruitment to the cell-cell contact initiation sites is inde-
pendent of cadherin-mediated adhesion (Thomas et al., 2004).
Therefore, JAM-A recruitment occurs substantially ahead of other
TJ transmembrane proteins, with occludin and claudin assem-
bly taking place from the late morula stage onwards (Thomas
et al., 2004; Eckert and Fleming, 2008). Importantly, only com-
pact embryos treated with an E-cadherin neutralizing antibody
disassemble rapidly, whereas inactivation of JAM-A does not
perturb compaction and only results in a delayed cavitation of
the embryo (Thomas et al., 2004). This result underscores the
importance of cadherin-based cell-cell adhesion during com-
paction and indicates that JAM-A cell surface expression does
not contribute to the initiation of cell adhesion per se within the
embryo.
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CELL POLARIZATION—A KEY STEP TOWARD BARRIER
FORMATION
The establishment of mutually exclusive cortical domains in
epithelia and endothelia in part relies on the asymmetric dis-
tribution of a set of evolutionary conserved biochemical fac-
tors controlling cell polarity. Genetic studies in C. elegans and
D. melanogaster have identified three polarity groups, the Crb,
Par, and Scrib groups, with the members of each group having
interdependent and partly antagonistic functions. Although the
majority of our understanding of the complex polarity signaling
pathways in mammals is based on studies carried out in 2D and
3D cultured epithelial cells more recent studies indicate that the
same set of proteins is critical for endothelial polarity (Lizama and
Zovein, 2013). The Par complex is located sub-apically in epithe-
lial cells and assembles around Par-6 isoforms (Macara, 2004).
Par6 binds atypical protein kinase C (aPKC) λ/ι or ξ and selec-
tively engages GTP-bound Cdc42 (Joberty et al., 2000; Johansson
et al., 2000; Lin et al., 2000), which stimulates the activity of
Par6-associated aPKC several-fold, potentially through a confor-
mational rearrangement of the complex. The Par6/aPKC complex
appears to be a general determinant of polarity, which undergoes
cell-specific interactions with other polarity proteins. Members of
the Par-complex act in synergy with the Crumbs/Pals/Patj group
of proteins to define the apical cell surface (Hurd et al., 2003;
Ebnet et al., 2008). As Jam-A (and all other isoforms; see fur-
ther below) directly interacts with Par3, it most likely serves as
a spatial landmark to tether the Par3/Par6/aPKC polarity com-
plex to the primordial junction. The expression of the Par6/aPKC
complex has been confirmed in brain endothelial cells (Daneman
et al., 2010a) and it has also been shown to be important for
the establishment of endothelial polarity and lumen formation
in general (Zovein et al., 2010). Genetic deletion of β1-integrin
results in decreased Par3 expression, leading to a loss of endothe-
lial polarity (Osada et al., 2011). More recently, it has been shown
that the non-canonical Wnt/planar cell polarity (PCP) pathway
contributes to TJ integrity of hCMEC/D3 cell in vitro, suggesting
that this pathway might act as a key regulator of the BBB in vivo
(Artus et al., 2014). However, similarly to what has been reported
for epithelial cells (Chen and Macara, 2005; Qin et al., 2005) the
knock-down of Par3 only delays but does not fully inhibit TJ
formation in brain endothelial cells.
The Crumbs group (Crb) localizes apically or at apical junc-
tions and consists of the transmembrane Crb proteins and the
large scaffolding proteins Pals1 and Patj through which the com-
plex physically is connected to the Par group via Par6 (Bilder et al.,
2003; Hurd et al., 2003; Assemat et al., 2008; Tepass, 2012). In
ECs tight junction integrity is also maintained by angiomotin and
angiomotin-like proteins (Amot, AmotL1), in part through the
action of the associated RhoGEF Syx and loss of any of these pro-
teins results in increased vascular permeability and/or reduced
sprouting angiogenesis (Garnaas et al., 2008; Zheng et al., 2009;
Ngok et al., 2012).
The basolateral region of epithelial cells is specified by a group
of tumor suppressor genes, the Scrib complex. These include
Scribble, which encodes a LAP protein (with leucine-rich repeats
and four PDZ domains), Dlg, a MAGUK protein, and Lgl, com-
prised of WD40 repeats (Yamanaka and Ohno, 2008). Scrib,
Dlg and Lgl are membrane-associated adaptors implicated in
cytoskeletal organization and protein trafficking and potentially
in coupling tissue architecture to withdrawal from the cell cycle.
Although little is known about Scribble in endothelial cells, a
recent study provides evidence that loss of Scrib does exhibit vas-
cular hemorrhaging suggestive of defective permeability barriers
and a likely role in endothelial cell tube formation and angiogen-
esis (Michaelis et al., 2013). In breast cancer epithelia Scribble
has been demonstrated to interact with TAZ, a member of the
Hippo signaling pathway (Cordenonsi et al., 2011). Interestingly,
knock-down of angiomotin-like 2 (amotL2), another member
of the hippo cascade with ties to the Crb-polarity complex,
results in decreased tubulogenesis in vitro (Wang et al., 2011).
Therefore, it is tempting to speculate that the opposing functions
of Crumbs/Amot and Scribble polarity complexes also antago-
nistically impact upon the Hippo pathway to regulate endothelial
polarity and lumen formation.
One of the essential polarity regulators from yeast toman is the
RhoGTPase Cdc42. In epithelial cells PTEN-mediated segrega-
tion of phosphoinositides has been shown to initiate polarization
by recruiting Cdc42 to apical domains (Martin-Belmonte et al.,
2007). Further, the small GTPase Rac1 has been shown to play an
important role downstream of the Par complex (Iden and Collard,
2008). Independent of their polarity actions the best studied func-
tion of Rho GTPases is their role als molecular organizers of the
actin cytoskeleton. These two processes are interconnected as cell
polarization and the establishment of a functional TJ also entails
a complex rearrangement of the actin cytoskeleton, microtubule
organizing centers, and the establishment of a vesicle trafficking
machinery, all together facilitating vectorial transport functions
(Rodriguez-Boulan and Macara, 2014).
After establishment of cell polarity additional junctional pro-
teins are being sequentially delivered to the site of the adhesion
structure resulting in the maturation of the adherens junc-
tion (AJ) and TJ (Eckert and Fleming, 2008). Initially, during
compaction an immature junction, containing AJ and TJ con-
stituents, is formed serving as an initial landmark which is
required for proper cell polarization. Next to cadherin-catenin
components, the TJ-related proteins ZO-1 (the shorter ZO-1α-
isoform) and JAM-A localize to the immature junction. In addi-
tion, the rab GTPase rab13 relocates early to the apico-lateral
contact site (Sheth et al., 2000). During the following 16-cell stage
the TJ proteins ZO-2 (Sheth et al., 2008) and cingulin (Javed
et al., 1993) enter the stage of junctional biogenesis and sub-
sequently the transmembrane proteins occludin and claudin-1
and -3 are targeted to the junction. Concomitantly the segre-
gation into an apical tight junction and an adherens junction
located more basally takes place (Rajasekaran et al., 1996; Sheth
et al., 2000). Interestingly, although the formation of tight junc-
tions and cell polarity are intimately related, in vitro the Par
protein- and Scribble-complex have minor effects on TJ estab-
lishment in epithelial cells. The knock-down of either protein only
delays but does not inhibit TJ formation (Chen andMacara, 2005;
Qin et al., 2005). In contrast, perturbation of the Crbs/Pals1/Patj
complex results in persistent TJ defects (Fogg et al., 2005; Shin
et al., 2005; Wang et al., 2007). As the junction further matures,
together with a complex rearrangement of the cytoskeleton and
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the establishment of a vectorial transport system, a permeability
seal is formed which is the prerequisite for the formation of the
nascent blastocoel cavity.
Similar to epithelial differentiation, blood vessel forma-
tion relies on cell-cell contact and apical-basal polarization
of endothelial cells prior to lumen formation and junctional
maturation. As already mentioned above, various models have
been proposed to explain vascular lumenization, including the
intracellular vacuole coalescence model (cell hollowing), or extra-
cellular vacuole exocytosis and lumenal repulsion model (cord
hollowing) (Iruela-Arispe and Davis, 2009; Zeeb et al., 2010;
Axnick and Lammert, 2012). While cell hollowing involves the
generation and fusion of intracellular vacuoles of individual cells,
cord hollowing is based on lumen formation between two ormore
ECs (or an EC cord) (Lubarsky and Krasnow, 2003; Blum et al.,
2008; Chung and Andrew, 2008; Lee and Bautch, 2011). Both
types of lumen formation make use of a similar set of proteins
and pathways and distinguishing them from each other in vivo
is a difficult task. Generally, lumina of small capillaries (maxi-
mum diameter of a single cell) are formed by cell hollowing while
lumenization of larger vessels follows the process of cord hollow-
ing. However, using a computational model of lumen formation
it was recently suggested that cell hollowing and cord hollowing
may operate in parallel (Boas and Merks, 2014).
The initial phase of cord hollowing is characterized by cell-
cell adhesion, exocytosis and apical membrane repulsion (see
Figure 2). Initial intercellular contacts are established by homo-
typic interaction of VE-cadherin and Pecam-1/CD31 which
are distributed along the entire contacting plasma membrane.
Additionally, the uniform distribution of the polarity proteins
Par3 in contacting ECs is indicative of a yet unpolarized state
of the cells. Besides VE-cadherin also N-cadherin was found
at EC contact sites, which is believed to increase the amount
of VE-cadherin at cell-cell contacts (Luo and Radice, 2005).
Subsequently, de-adhesive glycoproteins (CD34-sialomucins) are
delivered from cytoplasmic vesicles to the contacting plasma
membrane delineating the future apical surface. The specific tar-
geting of CD34-sialomucins to EC contact sites depends on VE-
cadherin and involves PTEN signaling together with PIP2/PIP3
conversion (Zeeb et al., 2010). It is believed that the negatively
FIGURE 2 | Vascular lumen formation by cord hollowing. (A) Intercellular
adhesion of two or more ECs is accomplished by homophilic interaction of
VE-cadherin and Pecam-1. (B) Following establishment of Par3-mediated
apicobasal polarity via ß-1 integrin matrix interaction and the adaptor protein
RASIP1, CD34-sialomucins (CD34 and podocalyxin; PODXL) are recruited to
cell-cell contacts delineating the future apical border. VE-cadherin is required
for specifically targeting CD34-sialomucins to contact sites, and the delivery
depends on PTEN-mediated transformation of PIP3 to PIP2. Rasip1 localizes
at inter-endothelial junctions and acts downstream of Rap1 (Ras-related
protein1), mediating EC-ECM adhesion and stabilizing junctional integrity by
actin bundling. In cooperation with Radil (ras-association and dilute
domain-containing protein), Rasip1 further inhibits Rho-mediated stress fiber
formation, thereby increasing endothelial barrier function. Further, CCM1
mediates the stabilization of β-catenin-containing endothelial cell-cell
junctions downstream of the Rap1 GTPase. (C) Due to the negatively
charged CD34-sialomucins, electrostatic repulsion leads to separation of the
contacting plasma membranes thereby creating a free (non-contacting)
surface and a small lumen between ECs. Concomitantly, cadherin-based AJs
are redistributed to lateral borders, indicating the establishment of a lateral
junctional complex. Following phosphorylation by protein kinase C, pMoesin,
the major ERM protein in endothelial cells, is recruited to the future apical
membrane and links CD34-sialomucins to F-actin, supporting cytoskeletal
rearrangements in ECs during lumen expansion. Further, non-muscle myosin
assembles at the apical plasma membrane and interacts with F-actin in
response to VEGF signaling to support lumen expansion and cell shape
changes. (D) Further maturation of the endothelial TJs is then mediated by
claudin-5, occludin, members of the junctional adhesion molecule (JAM)
family, or by EC-selective adhesion molecule (ESAM).
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charged extracellular domains of CD34 sialomucins initiate the
repulsion of opposing leaflets creating a narrow space between
the cells, commonly referred to as “slit formation” (Robbins and
Beitel, 2010; Strilic et al., 2010). One of the CD34-related sialo-
mucins is podocalyxin (PODXL). Originally, PODXL has been
described as the major sialoprotein in the glycocalyx of glomeru-
lar podocytes (Kerjaschki et al., 1986). However, it has been rec-
ognized early that PODXL is a widespread component of vascular
endothelial cells (Born and Palinski, 1985; Horvat et al., 1986).
It localizes to the luminal domain of endothelial plasma mem-
branes in a patchy distribution and is absent from the abluminal
aspect (Horvat et al., 1986). Although the function of endothelial
sialoproteins has long remained elusive, a role in regulating the
thrombogenic properties of the endothelial surface was proposed
(Gorog et al., 1982; Born and Palinski, 1985). More recently it has
been shown that PODXL (syn. gp135) is a key regulator of apical
domain structure establishment in epithelial cells (Meder et al.,
2005) and it recruits filamentous actin and ezrin to the plasma
membrane, inducing microvillus formation (Nielsen et al., 2007).
Interestingly, embryoid bodies lacking ZO-1 or ZO-1/ZO-2 (but
not ZO-2 alone) exhibit reduced expression of PODXL at the
apical plasma membrane and lack TJs in the extraembryonic
endoderm (Phua et al., 2014). Further, quantitative PCR profiling
of RNA samples from laser capture microdissected microvessels
revealed that PODXL is preferably expressed in brain microves-
sels (Agarwal et al., 2010) suggesting a role in BBB establishment
and/or function.
CD34-sialomucins are further linked to the actin cytoskele-
ton via protein kinase C- (PKC) phosphorylated moesin, thereby
contributing to cell shape changes during lumenization (Strilic
et al., 2009). Lumen extension then depends on cytoskeletal
rearrangements involving non-muscle myosin and recruitment
thereof to the apical F-actin is accomplished by activation of
the Rho-associated protein kinase (ROCK) and VEGF-A signal-
ing (reviewed in Lee and Bautch, 2011). Finally, the assembly
of CD34-sialomucins at the future apical membrane triggers the
redistribution of junctional proteins to the lateral border, con-
stituting the initial step in the formation of a lateral junctional
complex.
Disturbance of endothelial polarization is observed in cerebral
cavernous malformations (CCM), the most common vascu-
lar dysplasia in the brain, which is characterized by hemor-
rhagic stroke, focal neurological deficits and seizures (reviewed
in Draheim et al., 2014). CCM1 binds to and is regulated by the
small GTPase Rap1, enhancing the adhesive properties of VE-
cadherin (Glading et al., 2007). The CCM1 FERM domain is
unmasked by the activated Rap1, targeting CCM1 to the junc-
tion and promoting endothelial polarization in a Par-dependent
manner (Lampugnani et al., 2010) (see Figure 3). In the absence
of CCM1, endothelial lumenization is severely disturbed, as evi-
denced by grossly dilated capillaries and multicavernous struc-
tures (Clatterbuck et al., 2001). Endothelial-specific disruption
of the CCM1 gene in mice induces endothelial to mesenchymal
transition due to increased BMP6–SMAD signaling, a process
which is characterized by the loss of cell polarity, increased cell
proliferation and migratory capacity (Maddaluno et al., 2013).
Although CCM genes are inactivated in all types of endothelial
cells under pathological conditions, CCM lesions are mostly
apparent in the brain vasculature. Therefore, the loss of endothe-
lial polarity and the concomitant impaired astroglia-endothelial
interaction, which is imperative for BBB function, seems to be
the underlying cause of frequent vascular lesions in the brain
(Maddaluno et al., 2013). This and other studies elegantly demon-
strate that cell-cell adhesion and apical-basal polarization appears
to be a universal event preceding epithelial and endothelial tubu-
logenesis, a mechanism imperative for organ development and
vascularization.
Results from numerous studies on various developmental
models converge on a crucial role for apical membrane special-
ization prior to junctional maturation. The establishment of a
cadherin-based primordial junctional complex prior to segrega-
tion of a more apically located TJ appears to be a conserved step in
epithelial and endothelial differentiation. Besides the indispens-
ability of cadherin-based cell-cell contacts, the early and bi-phasic
role of ZO-1 isoforms appears to be crucial for endothelial and
epithelial barrier formation. Following de novo establishment of
tight junctions, a dizzying number of proteins localize to the cyto-
plasmic aspect of TJ not only ensuring the integrity of the barrier
but also allowing a remodeling and change in permeability prop-
erties in response to physiological and pathological stimuli. Of
the known TJ constituents, the zonula occludens (ZO) proteins lie
at the heart of the TJ cytoplasmic plaque. Below, the major tight
junction proteins are being discussed, focusing on proteins that
have been shown to localize to endothelial TJs.
TIGHT JUNCTION PROTEINS
MEMBRANE-SPANNING TJ CONSTITUENTS
Overall, 3 distinct TJ-associated transmembrane protein groups
can be distinguished (see Figure 4B): (1) claudins, a fam-
ily of proteins comprising at least 27 different members in
mammals (Mineta et al., 2011); (2) TAMPs (TJ-associated
MARVEL proteins)—a group of proteins containing the struc-
tural tetraspanning MARVEL motif, including occludin (Furuse
et al., 1993), tricellulin (Ikenouchi et al., 2005), and MarvelD3
(Steed et al., 2009); (3) Immunoglobulin superfamily membrane
proteins JAM-A/-B/-C (Martin-Padura et al., 1998; Aurrand-
Lions et al., 2000; Palmeri et al., 2000; Ebnet et al., 2003),
coxsackie adenovirus receptor (CAR) (Carson et al., 1999; Cohen
et al., 2001), and endothelial cell-selective adhesion molecule
(ESAM) (Nasdala et al., 2002).
Occludin was the first integral membrane protein shown to
localize to TJs (Furuse et al., 1993) and is characterized by four
transmembrane domains, a short intracellular turn, two extra-
cellular loops, and a long carboxy- and a short amino-terminal
cytoplasmic domain. Cis-oligomerization of occludin seems to be
mediated by the MARVEL motif (Blasig et al., 2006; Yaffe et al.,
2012), whereas the extracellular loops are believed to contribute
to the gate-keeping function of TJs. The last 150 aa of the carboxyl
terminus of occludin interact directly with F-actin (Wittchen
et al., 1999) and the scaffold proteins ZO-1 (Furuse et al., 1994),
ZO-2 (Itoh et al., 1999b), and ZO-3 (Haskins et al., 1998).
Information regarding the physiological relevance of the N-
terminal domain remains scarce. Using a yeast-based two-hybrid
screen the E3 ubiquitin protein ligase Itch was found to directly
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FIGURE 3 | VE-cadherin and CCM1 act in concert to establish
endothelial polarization and lumen formation. Rap1 regulates the
junctional localization of CCM1 and mediates CCM1 activity in endothelial
polarization and lumen formation. CCM1 stabilizes VE-cadherin at AJs, by
associating with ß-catenin and inhibiting dissociation of ß-catenin from
AJs. Thereby, nuclear accumulation of ß-catenin and ß-catenin
transcriptional signaling is impaired. VE-cadherin promotes the apical
localization and activation of the Par3 polarity complex. While VE-cadherin
is needed for phosphorylation of PKCξ, CCM1/Rap1 is responsible for the
junctional recruitment of the polarity complex. The accumulation of
podocalyxin (PODXL) at the presumptive apical membrane is controlled
by VE-cadherin and ß1 integrin. PODXL in turn recruits moesin and
filamentous actin (F-actin) to the apical domain initiating endothelial lumen
formation.
interact with the outermost NH2-terminal domain of occludin
(Traweger et al., 2002). Indeed, following VEGF-induced phos-
phorylation occludin is targeted for proteasomal degradation via
Itch, resulting in increased endothelial permeability (Murakami
et al., 2009). Occludin is targeted by several kinases and is phos-
phorylated on serine, threonine (Sakakibara et al., 1997; Wong,
1997), and tyrosine residues (Tsukamoto and Nigam, 1999; Chen
et al., 2002) and reversible phosphorylation is an important
regulatory mechanism to control TJ assembly and maintenance.
For example, endothelial cells subjected to shear stress showed
a significantly reduced, but tyrosine-phosphorylated pool of
occludin (DeMaio et al., 2001). However, controversial results on
the role of occludin phosphorylation in epithelial and endothelial
cells exist.
Early investigations led to the assumption that occludin is the
core transmembrane protein of TJs (Furuse et al., 1996;McCarthy
et al., 1996). However, the TJ scientific community was stunned
to learn that occludin is dispensable for the formation of tight
junction strands. Occludin-deficient ES cells were found to be
morphologically indistinguishable from their wild type counter-
parts (Saitou et al., 1998) and occludin-deficient mouse embryos
were viable and did not show any gross morphological alter-
ations of TJs (Saitou et al., 2000). However, phenotypically ocln-/-
animals displayed multiple histological abnormalities, including
chronic inflammation and hyperplasia of the gastric epithelium,
calcification of the brain, cortical bone thinning, and testicular
atrophy. Subsequent analysis of the knockout animals suggested
occludin may play a role in epithelial differentiation and prolifer-
ation (Schulzke et al., 2005). In man, mutations of the occludin
gene cause band-like calcification with simplified gyration and
polymicrogyria (BLC-PMG), a rare neurological disorder result-
ing in malformations of cortical development, implicating a role
of occludin for TJs at the BBB (O’Driscoll et al., 2010).Most likely,
other proteins of the TAMP family (i.e., tricellulin or MarvelD3)
act redundantly partially masking the function of occludin. In
summary, although occludin clearly is not of fundamental impor-
tance for the core TJ structure the findings outlined above suggest
that it has a regulatory and accessory function in TJ formation
and physiology.
After having realized that occludin is not the major TJ-
strand protein, the search for a new protein began. Furuse
and Tsukita identified small proteins that co-fractionated with
occludin in a junction-enriched chicken liver fraction (Furuse
et al., 1998). Since the initial discovery of these small proteins,
termed claudin-1 and claudin-2, a total of 27 different claudin
family members have been identified in man and mouse (Mineta
et al., 2011). Although the predicted protein folding topology of
claudins (21–28 kD) is very similar to that of occludin, they do
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FIGURE 4 | Transmembrane proteins of the TJ. (A) Cerebral endothelial cells
constitute the cellular building block of the BBB and control the para- and
transcellular routes via elaborate influx and efflux transporters and cell-cell
adhesion structures. Astroglial endfeet, neurons, and microglia which are
present at the neurovascular unit have been omitted for clarity. (B) Schematic
membrane-spanningmodelsof the transmembranecomponentspresentatTJs.
not share any sequence homology (Furuse et al., 1998). Several
gain-of-function and loss-of-function studies have led to the
current model that claudins are the prime transmembrane pro-
teins responsible for the formation of higher-order tight junction
strands. For example, claudin-1 deficient mice die shortly after
birth due to excessive transepidermal water loss (Furuse et al.,
2002) and claudin-11 knockout animals show a complete loss of
TJs in Sertoli cells, oligodendrocytes, and the marginal cells of the
inner ear (Gow et al., 1999, 2004; Mazaud-Guittot et al., 2010).
It is believed that claudins and TAMPs oligomerize in a homo-
and heterophilic fashion and TJ-strands are formed by mosaics
of different claudin-family members and the combination and
stoichiometry of various isoforms determines the charge- and
size-selective properties of the barrier (Sonoda et al., 1999;
Anderson and Van Itallie, 2009). Further, claudins show a tissue-
specific expression pattern, contributing to tissue specific barrier
properties. Therefore, for each tissue a unique combination of
claudins which oligomerize with other TAMPS most likely deter-
mines the paracellular tightness of the junction toward different
solutes.
Overall, claudins-1, -3, -5, -11, -14, -19 appear to be sealing
components of tight junctions and for several of them human
mutations have been characterized. Mutations in claudin-1 cause
the neonatal ichtyosis and sclerosing cholangitis (NISCH) syn-
drome. Claudin-14 mutations are the underlying cause of auto-
somal recessive deafness 29 and 49 and mutations in claudin-19
cause renal hypomagnesemia with ocular involvement. Next to
acting as “sealants” claudins have been proposed to form para-
cellular ion-selective channels (Amasheh et al., 2002) and so far
claudin-2, -10a, -10b, -15, and -17 have been shown to have
channel-forming properties. Whereas claudins-2, 10b, and 15
display cation selectivity, -10a and 17 have been described as
anion-selective channels (reviewed in Gunzel and Fromm, 2012).
At the BBB, mainly claudin-3 (Wolburg et al., 2003) and
claudin-5 (Morita et al., 1999) are being expressed, claudin-12
likely also being part of the BBB-TJ (Ohtsuki et al., 2007; Schrade
et al., 2012). Early studies also have demonstrated the presence
of claudin-1 at brain capillary endothelial cells (Liebner et al.,
2000a), however this was a false report due to antibody cross-
reactivity with claudin-3. Subsequent studies using claudin-1 spe-
cific antibodies failed to detect any claudin-1 in CNS parenchymal
microvessels and/or in primary mouse or human brain endothe-
lial cells (Wolburg et al., 2003; Hamm et al., 2004; Coisne et al.,
2005; Weksler et al., 2005).
Of those having been described so far, claudin-5 is the most
abundant isoform at the BBB as also shown by a SAGE analysis
of rat brain microvasculature (Enerson and Drewes, 2006). It is
crucial for the “tightness” of TJs at the mammalian BBB as its
deletion resulted in a size-selective opening of the BBB in vivo,
allowing the diffusion of molecules smaller than 800Da (Nitta
et al., 2003). Interestingly, the TJs of the BBB were morpholog-
ically normal, nevertheless the knockout of claudin-5 resulted
in early neonatal death. This study also shows that the increase
in paracellular flux is tolerated during embryogenesis, poten-
tially due to the presence of the placental barrier. This indicates
that the BBB in the mouse embryo is “immature,” even though
it already restricts the flux of blood-borne products into the
neuroparenchyma (see Figures 1C,D).
Additional data establishes the key role of claudin-5 and
claudin-3 in TJ integrity at the BBB. For example, overexpres-
sion of claudin-5 increases the paracellular tightness in cul-
tured brain microvascular endothelial cells (Ohtsuki et al., 2007)
and the selective loss of claudin-3 in experimental autoimmune
encephalomyelitis or human glioblastoma multiforme is associ-
ated with BBB breakdown, suggesting that it also contributes to
BBB integrity and function (Wolburg et al., 2003). Interestingly,
a specific role of claudin-3 at the BBB is also underscored by the
observation that its expression correlates with the maturation of
the BBB in response to Wnt/β-catenin signaling during develop-
ment (Liebner et al., 2008). However, the exact role of claudin-3
at the BBB remains to be seen.
The greatest sequence diversity of claudins is located in the
C-terminal domain, suggesting that their diverse functions are
in part conferred by their association with cytoplasmic proteins.
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Generally, the last C-terminal amino acids constitute a PDZ bind-
ing motif resulting in the recruitment of the TJ-plaque proteins
ZO-1, ZO-2, ZO-3 (Itoh et al., 1999a), which seem to instruct
claudins to form functional TJ strands (Umeda et al., 2006).
Similarly to occludin, claudins are also phosphorylated on serine
or threonine residues, regulating their function and intracellular
localization (Ishizaki et al., 2003; D’Souza et al., 2005; Ikari et al.,
2006; Aono and Hirai, 2008).
Next to bicellular contacts, the formation of specialized tri-
cellular contacts is required to maintain the integrity of cellular
sheets. At these contacts a specialized TJ structure (tTJs) is formed
where three sealing elements are in close apposition and form a
narrow tube in the intercellular cleft (Friend and Gilula, 1972;
Staehelin, 1973; Ikenouchi et al., 2005). Specialized transmem-
brane proteins, tricellulin and proteins of the angulin family are
located at these contacts and recently have been identified in
endothelial cells of the brain and retina (Mariano et al., 2013;
Iwamoto et al., 2014). Tricellulin shares some sequence simi-
larity with occludin and depending on the cell type can also
be found at bicellular contacts where it possibly acts as a sub-
stitute for occludin (Ikenouchi et al., 2005; Krug et al., 2009).
Taken together, TJ-associated MARVEL proteins are able to par-
tially exert redundant functions, but also show tissue-specific
expression and are involved in distinct aspects of tight junction
assembly, maintenance, and regulation (Raleigh et al., 2010).
So far, the last class of transmembrane proteins found to
localize to the TJ are members of the immunoglobulin super-
family. Junction adhesion molecules or more precisely the first
isoform JAM-A was identified by using monoclonal antibodies
raised against endothelial antigens (Martin-Padura et al., 1998).
They form homotypic cell-cell contacts between endothelial and
epithelial cells and are highly enriched at TJs (Bazzoni et al.,
2000a; Liu et al., 2000). JAMs are generally glycosilated and
encompass two extracellular variable type Ig domains and a single
transmembrane domain. Through a classical type II PDZ bind-
ing motif located in its outermost C-terminus JAM-A interacts
with several cytoplasmic proteins, aiding in the establishment
of the cytoplasmic plaque of TJs (Bazzoni et al., 2000b; Ebnet
et al., 2000; Martinez-Estrada et al., 2001; Hamazaki et al., 2002).
Interestingly, JAM-/- mice show little alterations of the overall
epithelial architecture in the intestinal tract, but display increased
colonic inflammation and paracellular permeability (Laukoetter
et al., 2007). Next to JAM-A, the closely related proteins JAM-B
(JAM2) and JAM-C (JAM3) have been cloned and characterized
(Aurrand-Lions et al., 2000; Cunningham et al., 2000; Palmeri
et al., 2000; Arrate et al., 2001; Aurrand-Lions et al., 2001). In
contrast to JAM-A, JAM-B/-C seem restricted to endothelial cells
and have been demonstrated to form heterodimers in cell-cell
contacts, thereby counteracting the interaction with the leuko-
cyte receptor alpha(M)beta2 integrin (Cunningham et al., 2002;
Lamagna et al., 2005). In humans, homozygous mutations of
JAM-C result in intracerebral hemorrhages, subependymal calci-
fication, and congenital cataracts (Mochida et al., 2010). However,
overall little is known about their exact role at the BBB.
Strikingly, among all TJ-associated transmembrane proteins
only JAM-A/-B/-C interact directly with the cell polarity protein
Par3 (Ebnet et al., 2001, 2003; Itoh et al., 2001). JAMs localize
to sites of early cell-cell contact formation, so called puncta
or primordial spot-like junctions, where they most likely “flag”
this region for the recruitment of the Par3/Par6/aPKC polar-
ity complex during early junctional biogenesis in epithelial and
endothelial cells (see also further above). Next to their involve-
ment in cell-cell adhesion JAMs also mediate the transendothelial
migration of leukocytes which is of particular importance for BBB
function (Fraemohs et al., 2004; Aurrand-Lions et al., 2005).
Four additional Ig-superfamily protein members have been
found to localize to TJs: CAR—coxsackie- and adenovirus recep-
tor (Cohen et al., 2001; Raschperger et al., 2006), CLMP-
coxsackie- and adenovirus receptor-like membrane protein
(Raschperger et al., 2004), JAM 4 (Hirabayashi et al., 2003),
and ESAM—endothelial cell-selective adhesion molecule (Hirata
et al., 2001; Nasdala et al., 2002). Of these, ESAM seems to be the
only endothelial-specific transmembrane protein. ESAM-/- mice
did not show any major vascular defects, however endothelial
tube formation was impaired suggesting a role of ESAM in cell-
cell contact formation (Ishida et al., 2003). More recently, ESAM
was also suggested to support the extravasation of neutrophils
during the early phase of an inflammatory response (Wegmann
et al., 2006).
Taken together, transmembrane proteins of the TJ not only
facilitate cell-cell adhesion and impede paracellular flux, they also
target cytoplasmic protein assemblies to distinct cell membrane
domains, endowing endothelial and epithelial cells with their
critical biological properties.
TJ CYTOPLASMIC PLAQUE PROTEINS
The most prominent subgroup of scaffolding proteins localizing
to tight junctions is represented by the MAGUK (membrane-
associated guanylate kinase) proteins (Dimitratos et al., 1999;
Gonzalez-Mariscal et al., 2000; Funke et al., 2005). The modular
nature of MAGUK proteins was early recognized as they all
share a common structural core consisting of one or several PDZ
domains and an SH3 domain followed by a catalytically inactive
guanylate kinase (GUK) domain (see Figure 5A). Originally,
MAGUKs only referred to a group of proteins including the
mammalian synaptic scaffold protein Psd-95, the Drosophila
tumor suppressor Dlg, and the tight junction protein ZO-1.
Since then a large number of scaffold proteins belonging to this
family have been identified. Generally, at junctions they serve
as molecular hubs coordinating large protein assemblies which
transduce the signals impinging on and emanating from the
apical plasma membrane, thereby influencing diverse cellular
processes, including the establishment and maintenance of cell
polarity and cell-cell adhesion complexes, synaptic plasticity,
and cell survival (Funke et al., 2005; Te Velthuis et al., 2007; De
Mendoza et al., 2010).
Stevenson and Goodenough identified the first TJ-associated
MAGUK ZO-1 (zonula occludens-1) by generating monoclonal
antibodies against a TJ-enriched plasma membrane fraction
from rodent liver (Stevenson et al., 1986). Subsequently, ZO-2
(Gumbiner et al., 1991) and ZO-3 (Balda et al., 1993; Haskins
et al., 1998) were discovered by co-immunoprecipitation stud-
ies. The ZO proteins are at the core of large protein networks
which are anchored to the TJ through their association with the
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FIGURE 5 | TJ-MAGUKS are membrane-associated adaptor proteins
assembling the tight junction plaque. (A) ZO-1, ZO-2, and ZO-3 are
multi-domain proteins composed of three PDZ domains, one SH3 and a
catalytically inactive GUK domain. Next to these MAGUK-related domains, ZO
proteins also contain various ZO-specific unique (U) and proline-rich (P)
regions. ZU5 is a region found in ZO-1 and Unc5-like netrin receptors.
(B) ZO-1 and ZO-2 are at the basis of large protein assemblies containing
structural and signaling molecules. Shown are proteins that have been
demonstrated to interact with ZO-1 or ZO-2 in epithelial and endothelial cells.
Gene symbols according to the H.G.N.C. nomenclature are indicated.
C-terminal domains of JAM-A (Bazzoni et al., 2000b; Ebnet et al.,
2000; Itoh et al., 2001), occludin (Furuse et al., 1994; Fanning
et al., 1998), and most claudins (Itoh et al., 1999a). They further
interact physically or functionally with a multitude of cytoplas-
mic proteins forming the TJ-plaque and they provide a direct link
to the actin cytoskeleton via a direct interaction with actin fila-
ments (Itoh et al., 1997; Fanning et al., 1998;Wittchen et al., 1999;
Fanning et al., 2002) or the actin binding proteins fodrin/spectrin,
cortactin, and protein 4.1R (Katsube et al., 1998; Mattagajasingh
et al., 2000). This association to intact cytoskeletal arrays is critical
for the physiology of cell–cell junctions.
ZO-1 and ZO-2 are expressed in both epithelial and endothe-
lial cells and have been shown to be indispensable for TJ- strand
formation (Umeda et al., 2006; Katsuno et al., 2008). ZO-3 seems
to be confined to epithelial cells (Inoko et al., 2003) and is less
critical for TJ function (Adachi et al., 2006; Xu et al., 2008).
Structurally, ZO proteins share a high degree of sequence sim-
ilarity across their protein-binding modules, however display
significant variability within their C-terminus suggesting that
these regions are functionally distinct. Next to the core MAGUK
domains of the ZO proteins, several unique (U) regions have been
identified (see Figure 5A). In the case of ZO-1 these regions influ-
ence its intracellular localization and its scaffolding properties
(Fanning et al., 2007; Fanning and Anderson, 2009), but little
is known about their relevance for ZO-2 and ZO-3. Although
the high sequence similarity also suggests a fair degree of func-
tional redundancy, specific roles have been described for the
different ZO proteins. Deficiency of ZO-1 results in mislocaliza-
tion of endothelial junctional adhesion complexes and defects in
angiogenesis were evident, resulting in early embryonic lethality
(Katsuno et al., 2008). Deletion of ZO-2 in mice is embry-
onic lethal shortly after implantation due to an arrest in early
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gastrulation, embryos showing a decreased proliferation rate and
an increase in apoptotic cells (Xu et al., 2008).
In brain cECs a decrease in the expression of ZO-1 and
occludin after cerebral embolism has been reported (Kago et al.,
2006) and in vitro under hypoxic conditions the localization of
ZO-1 and ZO-2 was altered with a concurrent decrease in TEER
(Mark and Davis, 2002; Fischer et al., 2004). Further, disrup-
tion of the TJs at the BBB occurs in many neurological disorders
(Rosenberg, 2012). However, in most cases the changes in TJ
structure and function are most likely the result of indirect down-
stream signaling events triggered secondary to an inflammatory
or traumatic event and are not directly exerted by the junctional
proteins themselves. Generally, the reduced expression of ZO-1
correlates with increased proliferation of cells and/or transfor-
mation. For example, in highly proliferative brain microvascular
endothelial cells from human brain tumors ZO-1 levels are low.
Apart from reduced expression, ZO proteins may also regulate
proliferation by nuclear translocation. A large body of evidence
demonstrates that ZO-1 and ZO-2 are not only present at cell-
cell junctions but also target the cell nucleus. Even though the
majority of these findings relate to epithelial cells, it is likely that
many of these processes also take place in endothelial cells. All
ZO proteins harbor conserved nuclear localization and nuclear
export sequences (Lopez-Bayghen et al., 2006) and in sparse cul-
tures, ZO-1 and ZO-2 are present in cell nuclei but become
re-distributed to the plasmamembrane as soon as cells reach con-
fluence (Gottardi et al., 1996; Islas et al., 2002; Traweger et al.,
2003; Jaramillo et al., 2004; Gonzalez-Mariscal et al., 2006). ZO-1
further perturbs gene expression by sequestering the Y-box tran-
scription factor ZONAB to the cytoplasm. ZONAB interacts with
the cell cycle regulator CDK4 and controls expression of cell cycle
regulators such as cyclin D1 and PCNA (for review see Balda and
Matter, 2009). ZO-2 has been shown to inhibit the transcription
of G1 cyclin after translocating to the nucleus (Gonzalez-Mariscal
et al., 2009). In addition, several proteins interact with ZO-2 dur-
ing nuclear shuttling or within the nucleus itself. For example,
the interaction of the armadillo-repeat protein ARVCF (armadillo
repeat gene deleted in velocardiofacial syndrome) depends on an
N-terminal PDZ domain of ZO-2 (Kausalya et al., 2004), a region
which is also targeted by the non-receptor tyrosine kinase JAK1.
Also, the transcription factors Jun, Fos, and C/EBP were shown
to associate with ZO-2 within the nucleus and at TJs in epithe-
lial cells (Betanzos et al., 2004). Next to directly associating with
and/or influencing transcription factors, ZO-2 possibly impacts
upon the transcription machinery via its association with the
hnRNP SAF-B/HET (Traweger et al., 2003), a molecular platform
which assembles a transcription complex in the vicinity of actively
transcribed genes (Renz and Fackelmayer, 1996). Taken together,
ZO proteins potentially act as direct or indirect regulators of cell
proliferation through nuclear translocation and/or their ability
to sequester transcription factors and signaling molecules to the
cytoplasm. However, our understanding of the signaling path-
ways and their biochemical properties through which ZO proteins
exert their effects beyond cell-cell adhesion remains fragmentary.
Next to the TJ-MAGUKs members of the so called MAGI pro-
tein family (membrane-associated guanylate kinase with inverted
orientation) localize to TJs. They are large adaptor proteins
containing 6 PDZ domains and a module of a GuK domain and
two WW domains C-terminal to the first PDZ domain. Of the
identified MAGI proteins, only MAGI-1 has been shown to local-
ize to TJs of brain endothelial cells where it interacts with ESAM
and promotes maturation of TJs in a Rho-dependent manner
(Wegmann et al., 2004; Kimura et al., 2010). In vascular endothe-
lial cells MAGI-1 physically interacts with β-catenin and localizes
to VE-cadherin-based AJs (Sakurai et al., 2006), however much
detail about the role of MAGI-1 at AJs and TJs is still missing.
Several other regulatory cytoplasmic plaque proteins have
been demonstrated to localize to the TJ-plaque, including het-
erotrimeric G-proteins (Denker et al., 1996; Fabian et al., 1998;
Saha et al., 1998). In brain capillary endothelial cells Gαi2 is
found in a complex together with claudin-5 and its depletion
results in increased paracellular permeability and delayed TJ-
formation after a hyperosmotic shock of cultured cECs (Luissint
et al., 2012). Another class of proteins influencing TJ physiology
are Rho family GTPases. In rat brain endothelial cells C3 trans-
ferase, a toxin which specifically inactivates RhoA-C, abrogated
lymphocyte transmigration, suggesting that Rho is required for
junction intergrity (Adamson et al., 1999). In addition, expression
of mutant Rho GTPases in epithelial and endothelial cells affected
barrier properties (Nusrat et al., 1995; Jou et al., 1998; Wojciak-
Stothard et al., 2001; Bruewer et al., 2004) and the paracellular
flux of sucrose was increased in cerebral endothelial cells treated
with lysophoshatidic acid (Schulze et al., 1997). So far, 3 TJ-
associated Rho-specific regulators have been identified. (1) The
Rho-activator GEF-H1 has been shown to regulate paracellular
permeability in epithelial and endothelial cells (Benais-Pont et al.,
2003; Birukova et al., 2006). (2) Tuba, an activator for Cdc42,
which is recruited to epithelial TJs in a ZO-1-dependent manner
(Otani et al., 2006). (3) The GAP protein SH3BP1 which restricts
the activity of Cdc42 and Rac when complexed with the scaf-
fold protein CD2AP, parcingulin, and the actin filament capping
protein CapZ (Elbediwy et al., 2012).
Cingulin and the closely related protein paracingulin (JACOP)
have also been shown to concentrate at TJs of epithelial and
endothelial cells, providing a direct link to the cytoskeleton
and to regulate the activity of Rho family GTPases at junc-
tions by recruiting guanidine exchange factors of RhoA and
Rac1 (Paschoud et al., 2011). Overall, little is known about how
the activities of RhoGTPases are regulated and how they feed
into the signaling networks that control tight junction forma-
tion and integrity. Most likely a Rho-dependent regulation of the
actinomyosin cytoskeleton perturbs TJ integrity.
Taken together, the modular structure of a set of adaptor
proteins allows the spatio-temporal assembly of multi-protein
complexes (see Figure 5B) at discrete regions of epithelial and
endothelial cells through their interaction with clustered trans-
membrane TJ proteins, not only ensuring the structural integrity
of the TJ, but also integrating various regulatory pathways at the
cytoplasmic plaque which are pivotal for TJ physiology.
THE NVU—COUPLING BBB INTEGRITY AND NEURONAL
ACTIVITY
The endothelial cells forming the lining of themicrovasculature of
the brain are set up to actively provide the brain with oxygen and
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essential nutrients, allowing not only a timely response to local
demands but also buffering, which is crucial to physiological neu-
ronal function (Abbott et al., 2006; Abbott, 2013). Brain cECs are
wrapped by pericytes, both sharing a common basement mem-
brane onto which astrocytes project their endfeet, ensheathing
over 95% of the abluminal microvascular surface (see Figure 4A).
In addition, cECs receive input from neurons.
Early in vivo grafting studies and experiments using astrocyte-
conditioned media highlighted the role of astrocyte-derived
secreted factors to influence the BBB properties of brain cECs
by inducing junction formation (Arthur et al., 1987; Janzer and
Raff, 1987; Tao-Cheng et al., 1987; Haseloff et al., 2005). Glial-
derived neurotrophic factor (GDNF) has been demonstrated to
enhance the barrier properties of brain cECs in vitro (Igarashi
et al., 1999) and FGF was found to decrease BBB permeability
(El Hafny et al., 1996), which is in line with the BBB integrity
loss seen in FGF-2−/−/FGF-5−/− double mutant mice (Reuss
et al., 2003). Recently, sonic hedgehog (Shh) has been shown to be
secreted by perivascular astrocytes and endothelial-specific dele-
tion of Smoothened (Smo), a downstream target of Shh, resulted
in incomplete BBB maturation early during mouse embryonic
development (Alvarez et al., 2011). Further, Shh knockout mice
displayed a decrease in TJ proteins in brain cECs.
Next to astrocytes, pericytes have been shown to directly influ-
ence the BBB (Hori et al., 2004; Daneman et al., 2010b). The
canonical Wnt/β-catenin has also been shown to influence TJ
integrity and BBB formation, increasing the expression of several
genes, including the TJ protein claudin-3 (Liebner et al., 2008;
Daneman et al., 2009). In vitro, activation of Wnt pathway con-
trols the expression several TJ proteins (Paolinelli et al., 2013).
Further, genetic ablation of Wnt7a/b results in the breakdown of
the BBB and a severe CNS-specific hemorrhaging phenotype early
in embryonic development (Stenman et al., 2008).
Next to astrocytes and pericytes, noradrenergic, serotoner-
gic, cholinergic, and GABA-ergic neurons have been found to
directly contact brain cECs (Cohen et al., 1996, 1997; Tong and
Hamel, 1999; Vaucher et al., 2000). It is believed that neurons
innervating the brain cECs and astrocytes of the NVU regulate
BBB permeability; however the mechanism of action remains
unknown.
Taken together, the BBB is a dynamic structure receiving
continuous input from the CNS. It is this intimate association
of cerebral endothelial cells with neuroectoderm-derived acces-
sory cells that influences barrier function (i.e., tightness) in a
spatio-temporal manner in the developing and mature brain.
CONCLUDING REMARKS
The basic structure of the BBB has been described more than
100 years ago. Much progress has been made on elucidating the
molecular programs that govern tight junction biogenesis and
many of the core molecular components of the endothelial TJ
complex which constitutes the main physical paracellular bar-
rier at the BBB have been identified. TJs are now appreciated as
dynamic structures where multiple signaling pathways converge,
fitting the BBB of the cerebral vascular bed with a high degree
of plasticity in response to physiological and pathological stimuli.
Next to cell-cell adhesion, processes such as cellular polarization,
cytoskeletal rearrangements, integrin-mediated attachment to the
ECM, and polarized trafficking are pivotal to the physiological
functioning of the BBB. These mechanisms have so far mainly
been described in epithelial cells and although most of the key
players are present in endothelial cells, their actions may vary
markedly in different physiological contexts. Therefore, it will
be central to gain a better understanding of the spatio-temporal
establishment of functional TJs at the BBB during early vascu-
larization of the embryonic brain. Clearly, further insights have
largely been hampered by the lack of suitable in vitro culture sys-
tems appropriately replicating the vascular properties of the brain
microcapillaries. As for many neurological diseases it remains
problematic to deliver appropriate drugs to the CNS, a transient
modulation of the TJs or transcytosis at the BBB may constitute
an alternative approach. Undoubtedly, a more detailed under-
standing of the complex structure and physiology of endothelial
TJs will aid in developing practical solutions for the future.
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